Exports determine Egis performance in future

Pharma

Exports will continue to determine the performance of Hungarian drug maker Egis Nyrt, while domestic sales grow at a slower pace, deputy-CEO László Marosffy told a press conference on Thursday after the publication of the company's Q1-Q3 report for its business year started October 1, 2005.
Egis expects domestic sales to increase just 9-10% in its 2005/2006 business year and 8-10% in its 2006/2007 business year, Marosffy said. He attributed the slowdown in sales to the slow expansion of Hungary's drug market, growing competition and the austerity measures recently announced by the government.
Egis expects exports to Russia and CIS countries to increase 35% in the 2005/2006 business year and 30% in the 2006/2007 business year. In Russia, Egis expects its products to remain on a list of drugs subsidized by the state. Egis targets a 13-15% increase in exports to Eastern Europe in the 2005/2006 business year, but slower growth in the following year. While exports to countries in the West are expected to slow in the 2005/2006 business year, growth is targeted in the following year.
On the domestic market, Egis expects changes to the drug subsidy system in force from July 1 to seriously affect its turnover, Marosffy said. Under the modified system, subsidies apply only to those drugs which are priced no more than 20% over a reference product picked by the state. Because of the measure, Egis lowered its prices an average 3% from July, which translates as an annual Ft 1 billionn fall in revenue. (Econews)

More Companies Take Action Against Corruption Analysis

More Companies Take Action Against Corruption

Karácsony Still Winner of Budapest Mayoral Election After Re... Elections

Karácsony Still Winner of Budapest Mayoral Election After Re...

2 Major Ground Handlers at Budapest Airport Join Forces Transport

2 Major Ground Handlers at Budapest Airport Join Forces

Summer Camp Prices Have Increased 10-15% Tourism

Summer Camp Prices Have Increased 10-15%

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.